Trial Profile
BNLI-FAD in newly diagnosed stage III or IV LGNHL [low grade non-Hodgkin's lymphoma] aged 55 years
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2005
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Dexamethasone (Primary) ; Doxorubicin (Primary) ; Fludarabine (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 03 Aug 2005 New trial record.